You can access any of the podium or poster presentations’ abstracts by searching for it below.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
DRUG USE EVALUATION FOR FLUNITRAZEPAM IN A 2000-BED MEDICAL CENTER IN TAIWAN
- In: Poster Session
- At: Düsseldorf (Germany) (2015)
- Type: Poster
- By: WU, Shang-Hua (China Medical University, School pf pharmacy, Taiwan (R.O.C.), China Taiwan)
- Co-author(s): Shang-Hua Wu
- Abstract:
Flunitrazepam (i.e., FM2), 3-class controlled substance in Taiwan, has the longer half-life. FM2 is approved for insomnia and used for anxiety and muscle relaxation, as off-label use.
A secondary data analysis using 2000-bed China Medical University Hospital (CMUH) in-house Medication Unitization Evaluation (MUE) databases was conducted. The FM2
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 2 July 2026